# Optimizing the Management of Sickle Cell Patients on Hydroxyurea: The Value of Therapeutic Pharmacological Monitoring

> **NCT06464458** · NA · RECRUITING · sponsor: **University Hospital, Strasbourg, France** · enrollment: 30 (estimated)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **OTHER:** management on hydroxyurea by therapeutic pharmacological monitoring

## Key facts

- **NCT ID:** NCT06464458
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-08
- **Primary completion:** 2025-08-07
- **Final completion:** 2025-08-07
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06464458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06464458, "Optimizing the Management of Sickle Cell Patients on Hydroxyurea: The Value of Therapeutic Pharmacological Monitoring". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06464458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*